T
Thomas J. Anderson
Researcher at University of Glasgow
Publications - 159
Citations - 9244
Thomas J. Anderson is an academic researcher from University of Glasgow. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 46, co-authored 159 publications receiving 8944 citations. Previous affiliations of Thomas J. Anderson include University of Edinburgh & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin
Ian R. Griffiths,Matthias Klugmann,Matthias Klugmann,Matthias Klugmann,Thomas J. Anderson,Thomas J. Anderson,Thomas J. Anderson,Donald Yool,Donald Yool,Donald Yool,Christine E. Thomson,Christine E. Thomson,Christine E. Thomson,Markus H. Schwab,Markus H. Schwab,Markus H. Schwab,Armin Schneider,Armin Schneider,Armin Schneider,Frank Zimmermann,Frank Zimmermann,Frank Zimmermann,Mailise McCulloch,Mailise McCulloch,Mailise McCulloch,Nancy Nadon,Nancy Nadon,Nancy Nadon,Klaus-Armin Nave,Klaus-Armin Nave,Klaus-Armin Nave +30 more
TL;DR: Fiber degeneration could indicate that myelinated axons require local oligodendroglial support, and two myelin membrane proteolipids, PLP and DM20, were shown to be essential for the integrity of myelination.
Journal ArticleDOI
The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2
Sunil R. Lakhani,Marc J. van de Vijver,Jocelyne Jacquemier,Thomas J. Anderson,Peter Osin,Lesley McGuffog,Douglas F. Easton +6 more
TL;DR: The combined morphologic and immunohistochemical data can be used to predict the risk of a young patient harboring a germline mutation in BRCA1, and the BRC a2 phenotype is currently not well defined.
Book
Diagnostic Histopathology of the Breast
David L. Page,Thomas J. Anderson +1 more
TL;DR: Anatomy of Breast Development, Stages of Breast development, and Sarcomas of the Breast: Major Histological Types.
Journal ArticleDOI
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Sunil R. Lakhani,Jocelyne Jacquemier,John P. Sloane,Barry A. Gusterson,Thomas J. Anderson,Marc J. van de Vijver,Linda M. Farid,Deon J. Venter,A C Antoniou,Amy Storfer-Isser,Elizabeth Smyth,C. Michael Steel,Neva E. Haites,Rodney J. Scott,David E. Goldgar,Susan L. Neuhausen,Peter A. Daly,Wilma Ormiston,Ross McManus,Siegfried Scherneck,Bruce A.J. Ponder,Debbie Ford,Julian Peto,Dominique Stoppa-Lyonnet,Yves-Jean Bignon,J. P. Struewing,Nigel K. Spurr,D. Timothy Bishop,J. G. M. Klijn,Peter Devilee,Cornelisse J. Cornelisse,Christine Lasset,Gilbert M. Lenoir,Rosa B. Barkardottir,Valgurdur Egilsson,Ute Hamann,Jenny Chang-Claude,Hagay Sobol,Barbara L. Weber,Michael R. Stratton,Douglas F. Easton +40 more
TL;DR: Key features of the histologic phenotypes of breast cancers in carriers of mutant BRCA1 and BRCa2 genes are identified and this information may improve the classification of breast cancer in individuals with a family history of the disease and may ultimately aid in the clinical management of patients.
Journal ArticleDOI
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Freda E. Alexander,Thomas J. Anderson,Heath Brown,A. P. M. Forrest,W. Hepburn,A.E. Kirkpatrick,B. B. Muir,Robin J Prescott,A. Smith +8 more
TL;DR: The findings confirm results from randomised trials in Sweden and the USA that screening for breast cancer lowers breast-cancer mortality and suggest benefit from introduction of screening before 50 years of age.